We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.60 | 0.55 | 0.65 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 390k | -385k | -0.0002 | -30.00 | 13.31M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/8/2016 19:22 | The fence welcomes everyone, and most of the silent majority are likely to be sat on it. The annual report will probsbly be too early for them to know, but it would be nice to get a trading update with the AGM statement giving an idea of how much income we're expecting from DSM for H1. I'm not really expecting that though, but they should be able to tell us what the revenue from FF+ is, and whether it's profitable. Wheelie will be selling some soon, and calming down a bit ...and fair play to him for making a profit. BB | bareknee | |
15/8/2016 12:28 | Oops, I'm going to sound like Bernie. :( You're both right yet both selective. WheelieBin; 40% rise is good and although I missed my limit order at 0.26p, my latest topup, albeit the only one, is in profit. If this rise is associated with fundamentals-changin RP; market expectations clearly have improved and it looks like we can reasonably assume further improvement from here. Look at me, it's a bloody miracle; I'm on the fence. Bernie would be so proud. If I were a ramper (which I'm not), now might be the right time to shout PXS from the rooftops of whatever sordid little office they work from. | librag | |
15/8/2016 01:00 | We have had a terrible last 5 years but all being well we are hopefully now on the mend which will be highlighted come this September..IMHO 07:00 02-Aug-2016 PXS Results of Placing RNS +2.44% Up 07:00 12-Jul-2016 PXS Study Publication RNS +5.39% Up 07:05 29-Jun-2016 PXS Funding Update RNS +8.61% Up 07:00 29-Jun-2016 PXS Product Launch RNS +8.61% Up July low share price 0.26p today 0.36p = 40% rise in one month. Preliminary Results September 2016 Annual General Meeting 30 September 2016 | wheelds | |
14/8/2016 12:23 | wheelds - market expectations have not imo improved at all.What evidence is there of that?A minor rise from woeful lows is not evidence of that. We are loss making with insufficient monies to guarantee even the next financial year.That is not an improvement.The last "fundraising" which was a mates rate discount fund raiser amounted to a temporary reprieve at best. Clutching at straws again. | redprince | |
14/8/2016 03:08 | It looks like the market expectations for Provexis has improved, and the rise in the share price seems to confirm this factor since the last fund raising to give us enough cash to keep going as revenues increase:- "In June 2015 the Company confirmed it had agreed significantly enhanced financial terms for its Alliance Agreement with DSM for Fruitflow®." | wheelds | |
05/8/2016 01:12 | "STATINS INCREASE RISK OF DIABETES" Says front page of Daily Express. "Doubling the costs to the N.H.S. in a decade to £1 billion a year." Front page of the Daily Express all about new evidence showing connection between taking Statins for heart health and triggering off diabetes in many and the number of people now developing Diabetes is on the increase. Good time to advertise in say the Daily Express or to get a reporter to check out our Fruitflow plus omega 3 compared to Statins for healthy heart with no side effects like Diabetes; and published the findings this week following on from this scare story.. In my opinion. . | wheelds | |
02/8/2016 08:41 | No surprise. The BoD putting their own money on the line though ... certainly IS. I've got a topup order in @ 0.26p, we'll see if it gets taken. GL. | librag | |
02/8/2016 08:38 | Placing. There's asurprise. LOL! More 'tomatoes tomorrow'?? They have been spinning this story for years, and years and..... Makes one wonder: if this supposedly soopa-doopa thingummy was indeed so miraculous, would it not have been snapped up by GSK &/or AZN a long time ago. | 2magpies | |
27/7/2016 16:56 | You can try Amazon for the juice or buy in tablet form direct from Provexis. | redprince | |
27/7/2016 11:55 | Good news! If you need shopping advice, you have a shopping choice, either the red channel or the blue channel. :) | librag | |
26/7/2016 21:45 | Sainsburys have stopped selling Sirco. Disaster! Anyone know where I can buy it now? Tia TFC | the fat controller | |
26/7/2016 14:19 | Graham Well done on St Ives, that's recovered nicely for you ! As far as Provexis goes, for me, without the BP R&D, this isn't really investable for me in in the short to medium term. Even stripping out the R&D costs of a bit under 200k / year, this could take 18+ months just to break even. We have to wait for the trial results come out, which should be looked on as a stop-go. If they show some statistical significance, then the BoD should be looking to fund the next stage. If not, then this is likely to continue to stagnate. Worst case is the results aren't very significant and we continue to throw cash at it to keep Dutta Roy sweet. DSM will buy us out if it's makes economic sense for them to do so. At the moment, with an annualised cost for them for the profit share of 100k and a market cap of ~4.5 million, they'd be nuts to try and take us out. BB | bareknee | |
22/7/2016 14:01 | LibraG - they need to detail grounds for exclusivity as non exclusive is a clear barrier to entry that suits their purpose and not ours. We could easily ask for eg 3 year limited exclusivity for certain launches which would buy us time. We must ask for shareholder representation on the Alliance - long overdue. We are being mugged off with an online product that does nothing to address our real concerns. | redprince | |
22/7/2016 10:27 | RP; be careful what you wish for. If PXS don't go for more fund raising to fund R&D, you might find that the BoD, in our "best interests" believe there's nothing to be gained from continuing in business. I know that we don't know what's really going on but you (and I) are rightly worried and suspicious that DSM might be deliberately playing a waiting game. Let's get some competition on what would otherwise be a monopoly control. Paranoid? You bet. Bernie: thoughts? | librag | |
20/7/2016 12:58 | Hopefully SIV will move following that :-). this looks like it might correct above >0.3p to me. could be wrong..... | senor_sensible | |
20/7/2016 12:21 | Hi SS; it's so interesting, .... not. SIV on the other hand - about time it woke up and £100K worth of director buys is great news ... shame about our BoD. | librag | |
20/7/2016 10:16 | interesting volume today... :-) | senor_sensible | |
12/7/2016 11:25 | Graham St Ives are a fairly well run company and did quite well for me for three or four years. They seem to have over reached themselves a bit. If you've spotted a technical bounce opportunity or something, then good luck. If you're in as something longer term then the next trading update will be important. I reckon there's a one in four chance of them raising some cash from the markets ( at a discount ). Obviously that means I think there's a three in four chance they won't, but, if you've read my witterings on them for the last few years you'll know their accounts are tough to get to the bottom of. They have a lot more debt now than they did three or four years ago, so I'm avoiding the temptation to buy back in just yet. As for Provexis, I'm wondering whether to put a bid into Primary Bid for a few k at .24p to see if they take it up at the same time as the hoped for placing. Can't be much more than a couple of months before they need the cash in the bank. BB | bareknee | |
08/7/2016 16:49 | LOL I knew you wouldn't be able to resist commenting on that ! Anyway, I've had a better look at it and it IS a very good paper and will be useful when talking to prospective customers ( companies ), but it's also preaching to the converted somewhat so it's just part of a tricky process to convince companies there's a decent sized market for Fruitflow. They need to sort out the short term finances though. Raising 185k may well not be enough to get the accounts signed off as a going concern. It'll be a bit touch and go. If you ( or anyone else reading this ) wants to buy say 5k or more in value of shares then I'd suggest you contact Ford and say you'll take [n]k's worth at .24 in the placing. BB | bareknee |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions